Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier
Zhuoya Wan, Haozhe Huang, Raymond E. West, Min Zhang, Bei Zhang, Xinran Cai, Ziqian Zhang, Zhangyi Luo, Yuang Chen, Yue Zhang, Wen Xie, Da Yang, Thomas D. Nolin, Junmei Wang, Song Li, Jingjing Sun
Topics & Concepts
StingCancer researchPancreatic cancerInnate immune systemTumor microenvironmentImmune systemMedicineChemokineImmunologyCancerInternal medicineAerospace engineeringEngineeringinterferon and immune responsesImmune cells in cancerImmune Cell Function and Interaction